Fingerprint
Dive into the research topics where Christopher Schwarz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI
Schwarz, C. (PI)
9/1/21 → 5/31/25
Project: Research project
-
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI
Schwarz, C. (PI)
9/15/20 → 8/31/21
Project: Research project
-
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change
Burkett, B. J., Wiste, H. J., Johnson, D. R., Boeve, B. F., Kantarci, K., Petersen, R. C., Knopman, D. S., Vemuri, P., Graff-Radford, J., Lowe, V., Cogswell, P. M., Pillai, J., Schwarz, C., Nguyen, A. T., Murray, M. E., Dickson, D. W. & Jack, C. R. J., May 2026, In: Alzheimer's and Dementia. 22, 5, e71449.Research output: Contribution to journal › Article › peer-review
Open Access -
AI-enhanced Centiloid quantification of amyloid PET images
for the Alzheimer's Disease Neuroimaging Initiative, OASIS3, the A4/LEARN Study Team, the AMYPAD consortium, The Health and Aging Brain Study (HABS-HD) Study Team, Mayo Clinic Study of Aging, WRAP, ADNI-DOD, PISA, ADNeT & the AIBL research group, Feb 2026, In: Alzheimer's and Dementia. 22, 2, e71162.Research output: Contribution to journal › Article › peer-review
Open Access -
Divergent white matter metabolic signature patterns indicate impending cognitive decline in aging and dementia
The Alzheimer's Disease Neuroimaging Initiative, Dec 2026, In: Nature communications. 17, 1, 4152.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial
Kantarci, K., Kara, F., Tosakulwong, N., Fought, A. J., Schwarz, C. G., Senjem, M. L., Kendall-Thomas, J., Min, P., Lowe, V. J., Jack, C. R., Kapoor, E., Fields, J. A., Bailey, K. R., James, T. T., Faubion, L., Lobo, R. A., Manson, J. A. E., Pal, L., Hammers, D. B. & Brinton, E. A. & 8 others, , Feb 2026, In: Alzheimer's and Dementia. 22, 2, e71067.Research output: Contribution to journal › Article › peer-review
Open Access -
Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron
Ono, D., Kondrakunta, S., Mak, E., Przybelski, S. A., Fought, A. J., Schwarz, C. G., Murray, M. E., Nguyen, A., Reichard, R. R., Senjem, M. L., Gunter, J. L., Jack, C. R., Miyagawa, T., Forsberg, L. K., Fields, J. A., Savica, R., Ramanan, V. K., Jones, D. T., Botha, H. & Louis, E. K. S. & 10 others, , Jun 2026, In: Acta neuropathologica. 151, 1, 17.Research output: Contribution to journal › Article › peer-review
Open Access